// Archived natural analysis section from MarketAnalysisBoard
// Kept for reference - original implementation of detailed market metrics

export const NaturalAnalysis = () => (
  <div className="natural-analysis">
    <h2>Natural Market Analysis</h2>
    <div className="analysis-grid">
      <div className="analysis-card">
        <h3>Market Overview</h3>
        <p>
          The cannabis market shows significant healthcare impact through:
          - 30% reduction in opioid prescriptions
          - £720 savings on benzodiazepines per patient
          - 20% reduction in psychiatric medication use
          - 15% reduction in sleep aid usage
          demonstrating substantial medication reduction potential.
        </p>
        <div className="analysis-metric">
          <span>Total Market Size</span>
          <small>System-wide Impact</small>
        </div>
      </div>

      <div className="analysis-card">
        <h3>Growth Dynamics</h3>
        <p>
          Early cannabis intervention in treatment-resistant conditions shows 
          significant cost savings through reduced traditional medication 
          dependence and improved patient outcomes.
        </p>
        <div className="analysis-metric">
          <span>Growth Rate</span>
          <small>Per-Patient Impact</small>
        </div>
      </div>

      <div className="analysis-card">
        <h3>Entry Opportunity</h3>
        <p>
          Cannabis therapies show particular promise in conditions with limited 
          traditional treatment options, offering new pathways for patient care 
          and cost reduction.
        </p>
        <div className="analysis-metric">
          <span>Accessible Segments</span>
          <small>Premium Impact</small>
        </div>
      </div>

      <div className="analysis-card">
        <h3>Market Dynamics</h3>
        <p>
          Strategic integration of cannabis therapies into existing treatment 
          protocols shows potential for £50-100M annual savings through reduced 
          traditional medication costs.
        </p>
        <div className="analysis-metric">
          <span>High Impact Segments</span>
          <small>Annual Treatment Savings</small>
        </div>
      </div>

      <div className="analysis-card">
        <h3>Barrier Distribution</h3>
        <p>
          Current challenges include regulatory compliance requirements, varying regional 
          acceptance levels, and integration with existing healthcare protocols.
        </p>
        <div className="analysis-metric">
          <span>Key Challenge Areas</span>
          <small>Avg Med Reduction</small>
        </div>
      </div>

      <div className="analysis-card">
        <h3>Strategic Approach</h3>
        <p>
          Success requires building clinical evidence bases, establishing dosing 
          standards, and developing partnerships with healthcare providers for 
          optimal patient outcomes.
        </p>
        <div className="analysis-metric">
          <span>Integrated Solutions</span>
          <small>Medication Savings</small>
        </div>
      </div>
    </div>
  </div>
);
